Skip to contentB
BioCorRx Inc.
B
BICXBioCorRx Inc. Q2 2013 · 10-Q
Revenue$499.95K$499.95K+179.0% vs Q2 2012 Net Income-$154.94K-$154.94KN/M vs Q2 2012 EPS Diluted$0.00$0.00— vs Q2 2012 Gross Profit$429,691+680.7% Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
BioCorRx Inc. · CIK 1443863 · Engraved from SEC EDGAR
derived
Free Cash Flowderived-$60,986— Margins · derivedGross margin85.9%+55.2 pt vs Q2 2012
Net margin-31.0%+191.5 pt vs Q2 2012
ended Jun 30, 2013 · filed Aug 19, 2013 · 50 d after period end